Effect of COVID-19 on liver transplantation in Korea

Transpl Infect Dis. 2020 Oct;22(5):e13384. doi: 10.1111/tid.13384. Epub 2020 Jul 13.

Abstract

COVID-19 is now a pandemic with increasing numbers of cases and deaths. In addition to the economic and social damage caused by COVID-19 outbreak prolongation, damage caused by delayed treatment of other diseases such as severe cirrhosis is also serious. We aimed to describe the effect of COVID-19 on the number of liver transplants (LT) in South Korea. The number of LT performed in Korea during the Middle East Respiratory Syndrome (MERS) outbreak, and the COVID-19 pandemic was compared with the average number of LT performed in the past 5 years. There were 108.5 cases of LT performed per month during the MERS outbreak. It was 11% lower than the average of 122.8 cases per month for the last 5 years. LDLT and DDLT decreased by 13% to 75.3 cases and by 7.5% to 33.2 cases per month during the MERS epidemic, respectively. From January to March 2020 (COVID-19 outbreak), the number of LT did not decrease significantly. The lockdown caused by COVID-19 did not affect the number of liver transplants in Korea. Establishing a safe process and procedure of liver transplantation within safe boundaries can be beneficial in reducing the side effects of lockdown and saving patients' lives.

Publication types

  • Comparative Study

MeSH terms

  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 / transmission
  • COVID-19 / virology
  • Communicable Disease Control / standards*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • End Stage Liver Disease / mortality
  • End Stage Liver Disease / surgery*
  • Humans
  • Liver Transplantation / methods
  • Liver Transplantation / standards
  • Liver Transplantation / statistics & numerical data*
  • Living Donors / statistics & numerical data
  • Middle East Respiratory Syndrome Coronavirus / pathogenicity
  • Pandemics / prevention & control
  • Republic of Korea / epidemiology
  • SARS-CoV-2 / pathogenicity
  • Waiting Lists / mortality